https://www.selleckchem.com/pr....oducts/oss-128167.ht
Renin-angiotensin system inhibitors (RASi) reduce mortality among heart failure (HF) patients, but their effect among those complicating contrast-induced acute kidney injury (CI-AKI) remains unexplored. We aimed to investigate whether the relationship between RASi prescription at discharge and mortality differs between HF patients with or without CI-AKI following coronary angiography (CAG). About 596 HF patients from an observational cohort were divided into a CI-AKI group ( = 104) and a non-CI-AKI group ( = 492) based on whether t
Like
Comment
Share
